Sign in

You're signed outSign in or to get full access.

Michael Gliedman

Chief Technology Officer at Ranpak HoldingsRanpak Holdings
Executive
Board

About Michael Gliedman

Michael S. Gliedman (61) is Ranpak’s Chief Technology Officer (since March 2020) and a Class I director (since June 2019), overseeing all aspects of technology for the company; he holds an MBA from Columbia Business School and a BA in Computer Science from Brandeis University . Prior roles include SVP/CIO at the National Basketball Association (1999–2017), SVP, Application Development at Viacom (1997–1999), and Principal at Booz Allen & Hamilton (1991–1997) . Company performance during his tenure shows cumulative TSR value of an initial $100 investment at $137.56 (2020), $384.65 (2021), $59.06 (2022), $71.41 (2023), and $84.42 (2024); Constant Currency AEBITDA was $93.7m (2020), $117.8m (2021), $66.8m (2022), $76.5m (2023), and $87.4m (2024) .

Past Roles

OrganizationRoleYearsStrategic Impact
National Basketball AssociationSVP & Chief Information Officer1999–2017Led technology strategy, systems implementation, cybersecurity, and fan-experience technology
ViacomSVP, Application Development1997–1999Directed application development programs
Booz Allen & HamiltonPrincipal, Media & Entertainment1991–1997Drove business-focused technology initiatives as a management consultant

External Roles

OrganizationRoleYearsStrategic Impact
Blue Strat AdvisorsManaging Director (founder)2017–presentTechnology strategy and digital transformation consulting

Board Governance

  • Director class and tenure: Class I director; director since 2019; term ends at the 2026 annual meeting .
  • Committee roles: No committee memberships listed for Gliedman in the directors table .
  • Independence: Not independent (Board determined seven independent directors; list excludes Gliedman) .
  • Board leadership and independent oversight: CEO also serves as Chairman; executive sessions of non-management directors are presided over by the NSG Committee Chair (Thomas F. Corley) .
  • Attendance: Each Board member attended ≥75% of Board and committee meetings in 2024 .
  • Director compensation: Employees serving as directors (including Gliedman) receive no additional director compensation . Non‑employee directors receive a $75,000 cash retainer plus ~ $100,000 annual equity grant (for context) .

Fixed Compensation

  • Specific CTO base salary, target bonus, and paid bonus amounts for Michael Gliedman are not disclosed in the proxy; the CD&A covers NEOs (CEO, CFO, regional MDs) and broader program design .

Performance Compensation

Company program (applicable to executives broadly):

  • Annual cash bonus metric (2024): Constant Currency AEBITDA; threshold $74.2m (15%), target $87.3m (100%), max $101.9m (200%); actual AEBITDA was $87.4m, yielding 100% payout for participants .
  • PRSUs (2024): Earn-out based on Constant Currency AEBITDA with threshold $74.2m (15%), target $87.3m (100%), max $100.4m (150%); actual AEBITDA of $87.4m resulted in 100% of target earned; PRSUs vest over three years .
  • RSUs: Time-based; 2024 RSUs vest over two years; starting in 2025 RSUs move to a three-year vesting schedule .
Metric (2024)ThresholdTargetMaximumActualPayout FactorVesting
Constant Currency AEBITDA – Cash Bonus$74.2m (15%) $87.3m (100%) $101.9m (200%) $87.4m 100% N/A (cash)
Constant Currency AEBITDA – PRSUs$74.2m (15%) $87.3m (100%) $100.4m (150%) $87.4m 100% 3-year vest

Note: The proxy does not specify Michael Gliedman’s individual grant sizes; table reflects company plan metrics and outcomes .

Equity Ownership & Alignment

  • Hedging/pledging: Prohibited for employees and directors; securities may not be held on margin .
  • Stock ownership guidelines: Executives must hold minimum multiples of salary; directors must hold ≥3x annual cash retainer; guidelines restrict selling if below thresholds (individual compliance not disclosed for Gliedman) .
Date (Record)Shares Beneficially Owned% of Outstanding
March 28, 202458,915 <1%
March 28, 202580,078 <1%

Employment Terms

  • Role start date: CTO since March 2020 .
  • Change-in-control treatment (plan level): Awards accelerate or convert per 2019 Omnibus Incentive Plan; if awards are not continued/converted, they vest and settle at change in control; if continued/converted, double‑trigger acceleration upon termination without cause within 24 months post‑CoC .
  • Award agreements: RSUs and PRSUs provide full or pro‑rata vesting under specified termination scenarios; LTIP PRSUs include special treatment on death, disability, CoC; these provisions are disclosed for NEOs and governed by plan terms for other executives .
  • Clawback: NYSE‑compliant recoupment policy adopted in October 2023 for incentive compensation upon material restatement; recovery is mandatory .

Performance & Track Record

Metric20202021202220232024
Company TSR – Value of $100 Investment$137.56 $384.65 $59.06 $71.41 $84.42
Net Income (Loss, $m)-$23.4 -$2.8 -$41.4 -$27.1 -$21.5
Constant Currency AEBITDA ($m)$93.7 $117.8 $66.8 $76.5 $87.4

Additional governance and shareholder feedback:

  • Say‑on‑Pay support: ~84% of votes cast in favor at the 2024 annual meeting; Compensation Committee monitors feedback and maintains pay‑for‑performance alignment .
  • Compensation peer group updates: 2025 group refreshed (adds ASPN, FTK, NNBR, PRLB, THR; removes CCF, CMCO, ESE, GLT, KAI); Ranpak’s revenue and market cap were at ~30th and 48th percentiles vs peers .

Director Compensation (Context and Dual-Role Implications)

  • Non‑employee director program: $75,000 annual cash retainer; committee chair fees ($20,000 Audit; $10,000 other; $15,000 Comp Committee chair starting 2025); ~$100,000 annual equity grant .
  • Dual‑role implication for Gliedman: As an employee director, he receives no additional director compensation; his director status is non‑independent, but he is not on Board committees, and independent committees provide oversight .

Investment Implications

  • Alignment: Prohibition on hedging/pledging and multi‑year vesting (PRSUs, RSUs) support long‑term alignment and reduce short‑term selling incentives; stock ownership guidelines further constrain dispositions if thresholds are unmet .
  • Retention risk: Three‑year PRSU and evolving three‑year RSU schedules enhance retention; award acceleration mechanics are conventional with double‑trigger protection under the plan, limiting abrupt turnover costs while preserving performance linkage .
  • Governance considerations: CTO’s board seat introduces non‑independence but is counterbalanced by fully independent Audit, Compensation, and Nominating/Sustainability/Governance committees and routine executive sessions led by an independent chair, sustaining oversight quality .
  • Ownership signal: Beneficial ownership increased from 58,915 shares (2024) to 80,078 (2025), still <1%, implying limited direct trading pressure from personal holdings while maintaining meaningful “skin‑in‑the‑game” for an operating executive .